senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm") system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
Company profile
Ticker
SENS
Exchange
Website
CEO
Timothy Goodnow
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Danaher • Roper • Fortive • Ametek • Sensata Technologies Holding • Keysight • MKS Instruments • Cognex • Hurco Companies • Sypris Solutions ...
Former names
ASN Technologies, Inc.
SEC CIK
SENS stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
12 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
PRE 14A
Preliminary proxy
2 Apr 24
8-K
Departure of Directors or Certain Officers
25 Mar 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
29 Feb 24
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4 Jan 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
9 Nov 23
Transcripts
SENS
Earnings call transcript
2023 Q4
29 Feb 24
SENS
Earnings call transcript
2023 Q3
9 Nov 23
SENS
Earnings call transcript
2023 Q2
10 Aug 23
SENS
Earnings call transcript
2023 Q1
9 May 23
SENS
Earnings call transcript
2022 Q3
9 Nov 22
SENS
Earnings call transcript
2022 Q2
10 Aug 22
SENS
Earnings call transcript
2022 Q1
11 May 22
SENS
Earnings call transcript
2021 Q4
2 Mar 22
SENS
Earnings call transcript
2021 Q3
10 Nov 21
SENS
Earnings call transcript
2021 Q2
10 Aug 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 55.76 mm | 55.76 mm | 55.76 mm | 55.76 mm | 55.76 mm | 55.76 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.34 mm | 6.46 mm | 5.75 mm | 6.04 mm |
Cash used (since last report) | n/a | n/a | 43.81 mm | 44.60 mm | 39.76 mm | 41.74 mm |
Cash remaining | n/a | n/a | 11.95 mm | 11.16 mm | 15.99 mm | 14.02 mm |
Runway (months of cash) | n/a | n/a | 1.9 | 1.7 | 2.8 | 2.3 |
Institutional ownership, Q3 2023
46.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 154 |
Opened positions | 20 |
Closed positions | 26 |
Increased positions | 28 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 45.36 bn |
Total shares | 246.87 mm |
Total puts | 468.44 k |
Total calls | 1.55 mm |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
PHCCF PHC | 86.89 mm | $80.39 mm |
Smith Robert J | 39.37 mm | $0.00 |
Vanguard | 22.24 mm | $13.43 bn |
Steward Capital | 19.00 mm | $55.29 mm |
Roche Finance | 17.52 mm | $59.93 mm |
New Enterprise Associates 10 L P | 14.47 mm | $5.46 mm |
BLK Blackrock | 11.59 mm | $7.00 bn |
Masters Capital Management | 7.00 mm | $4.23 bn |
Millennium Management | 5.80 mm | $3.50 bn |
Geode Capital Management | 4.93 mm | $2.98 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 24 | Prince Douglas S | Common Stock | Grant | Acquire A | No | No | 0.51 | 15,931 | 8.12 k | 648,782 |
2 Apr 24 | Fiorentino Edward | Common Stock | Grant | Acquire A | No | No | 0.51 | 27,696 | 14.12 k | 839,004 |
2 Apr 24 | Steven Edelman | Common Stock | Grant | Acquire A | No | No | 0.51 | 25,245 | 12.87 k | 770,919 |
2 Jan 24 | Prince Douglas S | Common Stock | Grant | Acquire A | No | No | 0.56 | 14,508 | 8.12 k | 632,851 |
News
HC Wainwright & Co. Reiterates Buy on Senseonics Holdings, Maintains $2 Price Target
11 Mar 24
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
1 Mar 24
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
1 Mar 24
Recap: Senseonics Holdings Q4 Earnings
29 Feb 24
Senseonics Holdings Q4 2023 GAAP EPS $(0.030) Beats $(0.040) Estimate, Sales $8.000M Beat $7.485M Estimate
29 Feb 24
Press releases
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS
12 Mar 24
Thinking about buying stock in Senseonics Holdings, Ainos, Marpai, Rush Street Interactive, or Evgo?
8 Mar 24
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
8 Mar 24
MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM
12 Feb 24
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
12 Feb 24